SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

 

SCHEDULE 13D

Under the Securities Exchange Act of 1934

(Amendment No. 2)*

 

 

Anheuser-Busch InBev SA/NV

(Name of Issuer)

Ordinary Shares, without par value

American Depositary Shares, each of which represents 1 (one) Ordinary Share,

without par value, evidenced by American Depositary Receipts

(Title of Class or Securities)

03524A108

(CUSIP Number for American Depositary Shares)

 

John Horsfield-Bradbury

Sullivan & Cromwell LLP

1 New Fetter Lane

London EC4A 1AN

England

+44 20 7959-8900

 

Erik Adam

Eugénie Patri Sébastien S.A.

488 Route de Longwy, L-1940,

Luxembourg

+ 352 27 02 39

 

Mr. Roberto Moses Thompson Motta

BRC S.à.R.L.

2 Boulevard de la Foire,

L – 1528 Luxembourg

+352 2704-8684

(Name, Address and Telephone Number of Person Authorized to Receive Notices and Communication)

November 22, 2021

(Date of Event to Which This Filing Relates)

 

 

If the filing person has previously filed a statement on Schedule 13G to report the acquisition that is the subject of this Schedule 13D, and is filing this schedule because of §§ 240.13d-1(e), 240.13d-1(f) or 240.13d-1(g), check the following box.  ☐

 

*

The remainder of this cover page shall be filled out for a reporting person’s initial filing on this form with respect to the subject class of securities, and for any subsequent amendment containing information which would alter disclosures provided in a prior cover page.

The information required on the remainder of this cover page shall not be deemed to be “filed” for the purpose of Section 18 of the Securities Exchange Act of 1934 (“Act”) or otherwise subject to the liabilities of that section of the Act but shall be subject to all other provisions of the Act (however, see the notes).

 

 

 

(Continued on following pages)


  1    

   Names of reporting persons:

 

  Stichting Anheuser-Busch InBev

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  The Netherlands

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,656,923 Shares1, 2

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,336,851 Ordinary Shares1

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,656,923 Shares1, 2

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.60%1, 2, 3

14  

  Type of reporting person (see instructions):

 

  CO

 

1

The Stichting Anheuser-Busch InBev (formerly Stichting InBev and Stichting Interbrew) is wholly-owned together by BRC S.à.R.L. (“BRC”) and EPS Participations S.à.R.L. (“EPS Participations”), which is wholly owned by Eugénie Patri Sébastien S.A. (formerly Eugénie Patri Sébastien SCA) (“EPS”). BRC is controlled by Jorge Paulo Lemann (“Mr. Lemann”), Carlos Alberto da Veiga Sicupira (“Mr. Sicupira”) and Marcel Herrmann Telles (“Mr. Telles”). The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax Société d’Investissements SA (“Rayvax”), a Belgian corporation, are party to the 2016 Shareholders’ Agreement (defined below), and the Stichting Anheuser-Busch InBev is party to a further voting agreement (the “Funds Voting Agreement”) with Fonds Baillet Latour CV (formerly Fonds Baillet Latour SPRL) (“Fonds Baillet Latour”) and Fonds Voorzitter Verhelst SRL (formerly Fonds Voorzitter Verhelst SPRL) (“Fonds Voorzitter Verhelst”). Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares (as defined below) of Anheuser-Busch InBev SA/NV (“AB InBev”), as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria Group, Inc. a Virginia Corporation (“Altria”) and BEVCO Lux S.à R.L., a Luxembourg corporation (“BEVCO”), are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares (as defined below) over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement (as defined below), which includes all Restricted Shares owned by Altria and BEVCO and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.60% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  BRC S.à R.L.

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Luxembourg

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,656,923 Shares1, 2

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,336,851 Ordinary Shares1

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,656,923 Shares1, 2

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.60%1, 2, 3

14  

  Type of reporting person (see instructions):

 

  CO

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.60% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  Eugénie Patri Sébastien S.A.

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Luxembourg

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,656,923 Shares1, 2

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,336,851 Ordinary Shares1

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,656,923 Shares1, 2

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.60%1, 2, 3

14  

  Type of reporting person (see instructions):

 

  CO

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). Includes Ordinary Shares beneficially owned by EPS which certain directors of EPS may have the right to acquire control of from EPS under certain circumstances. In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.60% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  Rayvax Société d’Investissements S.A.

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Belgium

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,656,923 Shares1, 2

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,336,851 Ordinary Shares1

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,656,923 Shares1, 2

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.60%1, 2, 3

14  

  Type of reporting person (see instructions):

 

  CO

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). Includes Ordinary Shares beneficially owned by EPS which certain directors of Rayvax may have the right to acquire control of from EPS under certain circumstances. In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.60% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  Fonds Baillet Latour CV

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Belgium

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,656,923 Shares1, 2

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,336,851 Ordinary Shares1

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,656,923 Shares1, 2

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.60%1, 2, 3

14  

  Type of reporting person (see instructions):

 

  CO

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.60% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  Fonds Voorzitter Verhelst SRL

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Belgium

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,656,923 Shares1, 2

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,336,851 Ordinary Shares1

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,656,923 Shares1, 2

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.60%1, 2, 3

14  

  Type of reporting person (see instructions):

 

  CO

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.60% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  Jorge Paulo Lemann

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Federative Republic of Brazil and Switzerland

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  259,000

     8   

  Shared voting power:

 

  1,141,225,054 Shares1, 2, 3

     9   

  Sole dispositive power:

 

  259,000

   10   

  Shared dispositive power:

 

  840,904,982 Ordinary Shares1, 3

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,141,225,054 Shares1, 2, 3

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.63%1, 2, 3, 4

14  

  Type of reporting person (see instructions):

 

  IN

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Includes 4,468 Ordinary Shares held by LTS Trading Company LLC as of November 22, 2021, a company incorporated under Delaware law, and 304,663 Ordinary Shares held by BR Global Investments Limited as of November 22, 2021, a company incorporated under the laws of the Bahamas, each acting in concert with Mr. Telles, Mr. Lemann and Mr. Sicupira within the meaning of Article 3, § 2 of the Belgian Law of 1 April 2007 on public takeover bids and 259,000 Ordinary Shares held by Olia 2 AG, a company incorporated under Liechtenstein law, acting in concert with Mr. Lemann within the meaning of Article 3, § 2 of the Belgian Law of 1 April 2007 on public takeover bids. Mr. Lemann disclaims beneficial ownership of the securities subject to this statement on Schedule 13D, except with respect to the 259,000 Ordinary Shares held by Olia 2 AG over which he holds sole voting and dispositive power.

4

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.63% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as November 22, 2021.


  1    

   Names of reporting persons:

 

  Carlos Alberto da Veiga Sicupira

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Federative Republic of Brazil

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  0

     8   

  Shared voting power:

 

  1,140,966,054 Shares1, 2, 3

     9   

  Sole dispositive power:

 

  0

   10   

  Shared dispositive power:

 

  840,645,982 Ordinary Shares1, 3

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,140,966,054 Shares1, 2, 3

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.62%1, 2, 3, 4

14  

  Type of reporting person (see instructions):

 

  IN

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Includes 4,468 Ordinary Shares held by LTS Trading Company LLC as of November 22, 2021, a company incorporated under Delaware law, and 304,663 Ordinary Shares held by BR Global Investments Limited as of November 22, 2021, a company incorporated under the laws of the Bahamas, each acting in concert with Mr. Telles, Mr. Lemann and Mr. Sicupira within the meaning of Article 3, § 2 of the Belgian Law of 1 April 2007 on public takeover bids. Mr. Sicupira disclaims beneficial ownership of the securities subject to this statement on Schedule 13D.

4

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.61% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.


  1    

   Names of reporting persons:

 

  Marcel Herrmann Telles

  2  

  Check the appropriate box if a member of a group (see instructions)

  (a)  ☒        (b)  ☐

 

  3  

  SEC use only

 

  4  

  Source of funds (see instructions):

 

  OO

  5  

  Check if disclosure of legal proceedings is required pursuant to Items 2(d) or 2(e)

 

  ☐

  6  

  Citizenship or place of organization:

 

  Federative Republic of Brazil

Number of

shares

 beneficially 

owned by

each

reporting

person

with

 

     7     

  Sole voting power:

 

  4,408,563

     8   

  Shared voting power:

 

  1,145,374,617 Shares1, 2, 3

     9   

  Sole dispositive power:

 

  4,408,563

   10   

  Shared dispositive power:

 

  845,054,545 Ordinary Shares1, 3

11    

  Aggregate amount beneficially owned by each reporting person:

 

  1,145,374,617 Shares1, 2, 3

12  

  Check if the aggregate amount in Row (11) excludes certain shares (see instructions)

 

  ☐

13  

  Percent of class represented by amount in row (11):

 

  57.84%1, 2, 3, 4

14  

  Type of reporting person (see instructions):

  IN

 

1

The Stichting Anheuser-Busch InBev is wholly-owned together by BRC and EPS Participations, which is wholly owned by EPS. BRC is controlled by Mr. Lemann, Mr. Sicupira and Mr. Telles. The Stichting Anheuser-Busch InBev, BRC, EPS Participations, EPS and Rayvax are party to the 2016 Shareholders’ Agreement, and the Stichting Anheuser-Busch InBev is party to the Funds Voting Agreement with Fonds Baillet Latour and Fonds Voorzitter Verhelst. Together these entities and individuals indirectly and directly beneficially own 840,336,851 Ordinary Shares of AB InBev, as of November 22, 2021, representing approximately 42.43% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). In addition, See Items 2, 3, 4, 5 and 6 of this Schedule 13D.

2

Includes (i) the 185,115,417 Restricted Shares and 12,341,937 Ordinary Shares of AB InBev beneficially owned by Altria and (ii) the 96,862,718 Restricted Shares and 6,000,000 Ordinary Shares of AB InBev beneficially owned by BEVCO. The Stichting Anheuser-Busch InBev, Altria and BEVCO are parties to the Restricted Shareholder Voting Agreement. The Restricted Shares vote together with the Ordinary Shares together on all matters requiring a vote of the shareholders of AB InBev, except that, as long as there remain any Restricted Shares, any modification of the rights attached to the Ordinary Shares or the Restricted Shares shall be made in accordance with the quorum and majority requirements of article 7:155 of the Belgian Companies and Associations Code.

3

Includes 4,468 Ordinary Shares held by LTS Trading Company LLC as of November 22, 2021, a company incorporated under Delaware law, and 304,663 Ordinary Shares held by BR Global Investments Limited as of November 22, 2021, a company incorporated under the laws of the Bahamas, each acting in concert with Mr. Telles, Mr. Lemann and Mr. Sicupira within the meaning of Article 3, § 2 of the Belgian Law of 1 April 2007 on public takeover bids and 4,408,563 Ordinary Shares held by Santa Paciencia Limited, a company incorporated under the laws of the Bahamas, acting in concert with Mr. Telles within the meaning of Article 3, § 2 of the Belgian Law of 1 April 2007 on public takeover bids. Mr. Telles disclaims beneficial ownership of the securities subject to this statement on Schedule 13D, except with respect to the 4,408,563 Ordinary Shares held by Santa Paciencia Limited. over which he holds sole voting and dispositive power.

4

Based on a total of 1,980,250,801 Ordinary Shares deemed to be outstanding as of November 22, 2021, which is calculated based upon the sum of (i) 1,698,272,666 Ordinary Shares issued and outstanding as of such date and (ii) 281,978,135 Ordinary Shares issuable upon the conversion of Restricted Shares over which the reporting parties may be deemed to have shared voting power by virtue of the Restricted Shareholder Voting Agreement, which includes all Restricted Shares owned by Altria and BEVCO, and no Restricted Shares owned by other holders. The shares set out above represent approximately 57.84% of the total shares with voting rights (i.e., 1,698,272,666 Ordinary Shares and 282,126,242 Restricted Shares) issued and outstanding as of November 22, 2021.

 


This Amendment No. 2 (this “Amendment”) amends and supplements the statement on Schedule 13D filed by the Reporting Persons with the Securities and Exchange Commission (the “SEC”) on November 2, 2016, as amended by Amendment No. 1 filed by the Reporting Persons with the SEC on June 16, 2021 (the “Schedule 13D”), relating to the ordinary shares, without par value (the “Ordinary Shares” of Anheuser-Busch InBev SA/NV (the “Issuer”). This Amendment is being filed to reflect the conversion of certain Restricted Shares into Ordinary Shares at the election of holders, which has increased the total amount of Ordinary Shares outstanding. Information reported in the Schedule 13D remains in effect except to the extent that it is amended, supplemented, restated or superseded by information contained in this Amendment. Each capitalized term used herein but not defined in this Amendment shall have the meaning assigned to such term in the Schedule 13D.

Item 1. Security and Issuer.

Item 2. Identity and Background.

Item 2 of the Schedule 13D is hereby amended and restated to read as follows.

(a), (b), (c), (f) This Schedule 13D is being filed by:

 

  (i)

the Stichting Anheuser-Busch InBev (formerly Stichting InBev and Stichting Interbrew), a foundation formed under the laws of the Netherlands (the “Stichting”);

 

  (ii)

BRC S.à R.L., a limited liability company (société à responsabilité limité) incorporated under the laws of Luxembourg (“BRC”);

 

  (iii)

Eugénie Patri Sébastien S.A. (formerly Eugénie Patri Sébastien SCA), a public limited liability company (société anonyme) incorporated under the laws of Luxembourg (“EPS”);

 

  (iv)

Rayvax Société d’Investissements S.A., a public limited liability company (société anonyme) incorporated under the laws of Belgium (“Rayvax”);

 

  (v)

Fonds Baillet Latour CV (formerly Fonds Baillet Latour SPRL), a foundation with a social purpose incorporated under the laws of Belgium (“Fonds Baillet Latour”);

 

  (vi)

Fonds Voorzitter Verhelst SRL (formerly Fonds Voorzitter Verhelst SPRL), a foundation with a social purpose incorporated under the laws of Belgium (“Fonds Voorzitter Verhelst”);

 

  (vii)

Jorge Paulo Lemann, a Swiss and Brazilian citizen (“Mr. Lemann”);

 

  (viii)

Carlos Alberto da Veiga Sicupira, a Brazilian citizen (“Mr. Sicupira”); and

 

  (ix)

Marcel Herrmann Telles, a Brazilian citizen (“Mr. Telles”), (collectively, the “Reporting Persons”).

The Stichting is a foundation, substantially all of the assets of which, as of November 22, 2021, were 663,074,832 Ordinary Shares, representing approximately 33.48% of the voting rights attached to AB InBev shares (excluding treasury shares held by AB InBev or its subsidiaries). The address of the principal business office of the Stichting is Amstelveenseweg 760, 1081 JK Amsterdam, the Netherlands. The principal business purposes of the Stichting is to hold AB InBev shares on behalf of EPS and its wholly owned subsidiary EPS Participations S.à R.L. (“EPS Participations”) and BRC. Each of EPS, EPS Participations and BRC holds Stichting certificates entitling them to claim from the Stichting the payment of any dividends and other amounts paid or distributed by AB InBev to the holders of the Ordinary Shares who hold their interests through the Stichting.

BRC is an investment company, the principal business purposes of which is holding Class B certificates of the Stichting (each of which represents one Ordinary Share held by the Stichting). The address of the principal business office of BRC is 2, Boulevard de la Foire, L—1528 Luxembourg.


EPS is a company established for the purpose of directly or indirectly investing in and holding Class A certificates of the Stichting (each of which represents one Ordinary Share held by the Stichting) and Ordinary Shares. The address of the principal business office of EPS is Route de Longwy 488, L-1940 Luxembourg. Certain of the securities being reported on by EPS on this Schedule 13D are actually held by EPS Participations, S.à R.L., a direct wholly owned subsidiary of EPS.

Rayvax is a company established for the purpose of holding an indirect interest in AB InBev. The address of the principal business office of Rayvax is 19, Square Vergote, B-1200 Brussels, Belgium. Certain of the securities being reported on by Rayvax on this Schedule 13D are actually held by Sébastien Holding NV/SA, a direct wholly owned subsidiary of Rayvax.

Fonds Baillet Latour is a foundation established with a social purpose to encourage and financially support projects with a high human or cultural value in the areas of medical research, education, culture and Olympic sport. The address of the principal business office of Fonds Baillet Latour is Grand’Place 1, 1000 Brussels, Belgium.

Fonds Voorzitter Verhelst is foundation established with a social purpose to financially assist AB InBev employees (e.g., with respect to their and their children’s education, health plans and medical care). The address of the principal business office of Fonds Voorzitter Verhelst is Brouwerijplein 1, 3000 Leuven, Belgium.

Mr. Lemann’s principal occupation is being a private investor and a director of BRC and the Stichting. His principal business address is Zücherstrasse 325, 8645 Jona, Switzerland.

Certain of the securities being reported on by Mr. Lemann on this Schedule 13D are actually held by LTS Trading Company LLC and BR Global Investments Limited, each an entity controlled jointly by Mr. Lemann, Mr. Sicupira and Mr. Telles. In addition, certain of the securities being reported on by Mr. Lemann on this Schedule 13D are actually held by Olia 2 AG, a company controlled by Mr. Lemann.

Mr. Sicupira’s principal occupation is being a private investor and a director of BRC and the Stichting. His principal business address is Rua Suiça, 260, Jd Europa, 01449-030, Sao Paulo-SP, Brazil. Certain of the securities being reported on by Mr. Sicupira on this Schedule 13D are actually held by LTS Trading Company LLC and BR Global Investments Limited, each an entity controlled jointly by Mr. Lemann, Mr. Sicupira and Mr. Telles.

Mr. Telles’ principal occupation is being a private investor and a director of BRC and the Stichting. His principal business address is Rua Dr Renato Paes de Barros, 1017, Itaim Bibi, 04530-001, Sao Paulo, Brazil. Certain of the securities being reported on by Mr. Telles on this Schedule 13D are actually held by LTS Trading Company LLC and BR Global Investments Limited, each an entity controlled jointly by Mr. Lemann, Mr. Sicupira and Mr. Telles. In addition, certain of the securities being reported on by Mr. Telles on this Schedule 13D are actually held by Santa Paciencia Limited, a company controlled by Mr. Telles.

The name, citizenship, business address and present principal occupation or employment of each of the directors of the Stichting, BRC, EPS, Rayvax, Fonds Baillet Latour and Fonds Voorzitter Verhelst and the name, principal business and address of the corporation or other organization in which any such employment is conducted are set forth in Annexes A-1 through A-7 to this Schedule 13D. None of such entities has any executive officers.

(d), (e) During the last five years, none of the Reporting Persons or director of the Stichting, BRC, EPS, Rayvax, Fonds Baillet Latour or Fonds Voorzitter Verhelst or any executive officer or director of any controlling shareholder, if any, of the Stichting, BRC, EPS, Rayvax, Fonds Baillet Latour or Fonds Voorzitter Verhelst has been convicted in a criminal proceeding (excluding traffic violations or similar misdemeanors) or been a party to a civil proceeding of a judicial or administrative body of competent jurisdiction and as a result of such proceeding was or is subject to a judgment, decree or final order enjoining future violations of, or prohibiting or mandating activities subject to, federal or state securities laws or finding any violation with respect to such laws.


Item 3. Source and Amount of Funds or Other Consideration.

Item 4. Purpose of Transaction.

Item 5. Interest in Securities of the Issuer.

Item 5 is hereby amended and restated in its entirety to read as follows.

 

(a)

Rows (11) and (13) of the cover pages to this Schedule 13D are hereby incorporated by reference.

 

(b)

Rows (7) through (10) of the cover pages to this Schedule 13D set forth the number of Ordinary Shares as to which there is sole power to vote or direct the vote or to dispose or to direct the disposition, and the number of Ordinary Shares and Restricted Shares of AB InBev as to which there is shared power to vote or to direct the vote, or shared power to dispose or to direct the disposition.

 

(c)

None of the Reporting Persons nor, to the knowledge of the Reporting Persons, any person identified on Schedule A to this Schedule 13D has effected any transaction in the Voting Shares of the Issuer during the past 60 days.

Except as described in this Schedule 13D, no other person is known to have the right to receive or the power to direct the receipt of dividends from, or the proceeds from the sale of, the Ordinary Shares owned, directly or indirectly, by the Reporting Persons.

Item 6. Contracts, Arrangements, Understandings or Relationships With Respect to Securities of the Issuer.


Item 7. Material to Be Filed as Exhibits.

 

Exhibit No   

Description

2.1    Consolidated Articles of Association of Anheuser-Busch InBev SA/NV (English-language translation) (incorporated by reference to Exhibit 99.1 to the Current Report on Form 6-K filed by Anheuser-Busch InBev SA/NV on May 13, 2021).
2.2    2016 AK Shareholders’ Agreement, dated April 11, 2016 (incorporated by reference from Amendment No. 16 to the Schedule 13D relating to Ambev S.A. filed by (among others) Former AB InBev, the Stichting and EPS on April 18, 2016).
2.3    Funds Voting Agreement, effective November 1, 2015 (incorporated by reference to Amendment No. 15 to the Schedule 13D relating to Ambev filed by (among others) Former AB InBev, the Stichting and EPS on March 9, 2015).
2.4    Voting and Support Agreement relating to Anheuser-Busch InBev SA/NV, dated October 8, 2016 (incorporated by reference to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on November 2, 2016).
2.5    Powers of Attorney (incorporated by reference to the Amendment No. 1 to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on June 16, 2021).
2.6    Powers of Attorney (incorporated by reference to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on November 2, 2016).
2.7    Joint Filing Agreement pursuant to Rule 13d-1(k) (incorporated by reference to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on November 2, 2016).


ANNEX A-1

Directors of the Stichting

 

Name

  

Citizenship

  

Business Address

  

Present Principal Occupation

  

Beneficial
Ownership of

AB InBev

Ordinary

Shares

Jorge Paulo Lemann    Brazil—Switzerland    Zürcherstrasse 325, 8645 Jona, Switzerland    Director of BRC and the Stichting.    1,141,225,054
Carlos Alberto da Veiga Sicupira    Brazil    Rua Suiça, 260, Jd Europa, 01449-030, Sao Paulo, Brazil    Director of BRC and the Stichting    1,140,966,054
Marcel Herrmann Telles    Brazil    Rua Dr Renato Paes de Barros, 1017, Itaim Bibi, 04530-001, Sao Paulo, Brazil    Director of BRC and the Stichting    1,145,374,617
Roberto Moses Thompson Motta    Brazil    Via Concordia 6, 6900, Lugano, Switzerland    Director of BRC, the Stichting and AB InBev    <0.1%
Paul Cornet de Ways Ruart    Belgium    Brouwerijplein 1, 3000 Leuven, Belgium    Director of AB InBev, the Stichting and EPS    <0.1%
Alexandre Van Damme    Belgium    Brouwerijplein 1, 3000 Leuven, Belgium    Director of AB InBev, the Stichting and EPS    0.105%
Grégoire de Spoelberch    Belgium    Brouwerijplein 1, 3000 Leuven, Belgium    Director of AB InBev, the Stichting and EPS; CEO of GDS Consult SA1    <0.1%
Sabine Chalmers    United States    Brouwerijplein 1, 3000 Leuven, Belgium    Director of AB InBev, the Stichting and EPS and Group General Counsel of BT Group Plc2    <0.1%

 

1

The principal business of GDS Consult SA is private equity and real estate investments and its address is Rue de l’Eglise 147, B-1150 Woluwe St. Pierre, Belgium.

2

The principal business of BT Group Plc is developing and selling communications propositions and services and its principal business address is BT Centre, 81 Newgate St, London EC1A 7AJ, United Kingdom.


ANNEX A-2

Directors of BRC

 

Name

  

Citizenship

  

Business Address

  

Present Principal Occupation

  

Beneficial
Ownership of

AB InBev

Ordinary

Shares

Paulo Alberto Lemann    Brazil—Switzerland    2627, South Bayshore Drive, Unit 3002, 33133-5438, Florida, USA    Director of BRC and AB InBev    <0.1%
Jorge Paulo Lemann    Brazil—Switzerland    Zürcherstrasse 325, 8645 Jona Switzerland    Director of BRC and the Stichting    1,141,225,054
Carlos Alberto da Veiga Sicupira    Brazil    Rua Suiça, 260, Jd Europa, 01449-030, Sao Paulo, Brazil    Director of BRC and the Stichting    1,140,966,054
Marcel Herrmann Telles    Brazil    Rua Dr Renato Paes de Barros, 1017, Itaim Bibi, 04530-001, Sao Paulo, Brazil.    Director of BRC and the Stichting    1,145,374,617
Roberto Moses Thompson Motta    Brazil    Via Concordia 6, 6900, Lugano, Switzerland    Director of BRC, the Stichting and AB InBev    <0.1%
Alexandre Behring    Brazil    Av Nacoes Unidas, 13797, Bloco III, 15th Floor, Vila Gertrudes 04794-000, Sao Paulo, Brazil    Director of BRC    <0.1%
Eduardo Saggioro    Brazil    Rua Dr Renato Paes de Barros, 1017, Itaim Bibi, 04530-001, Sao Paulo, Brazil    Director of BRC    <0.1%
Marc Lemann    Brazil—Switzerland    Rua Inglaterra, 426, 01447-020, Sao Paulo, Brazil    Director of BRC    <0.1%
Cecilia Sicupira    Brazil    Rua Dr Renato Paes de Barros, 1017, Itaim Bibi, 04530-001, Sao Paulo, Brazil    Director of BRC and AB InBev    <0.1%
Claudio Garcia    Brazil    944, Park Avenue, Apt 2, 10028, New York, USA    Director of BRC and AB InBev    <0.1%


ANNEX A-3

Directors of EPS

 

Name

  

Citizenship

  

Business Address

  

Present Principal Occupation

  

Beneficial
Ownership of

AB InBev

Ordinary

Shares

Sabine Chalmers    United States    c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940 Luxembourg    Director of AB InBev, the Stichting and EPS and Group General Counsel of BT Group Plc1    < 0.1%
Juan de Hemptinne    Belgium   

c/o Eugenie Patri Sebastien S.A.,

488, route de Longwy, L-1940 Luxembourg

   Director of EPS    < 0.1%
Christophe d’Ansembourg    Luxembourg   

c/o Eugenie Patri Sebastien S.A.,

488, route de Longwy, L-1940 Luxembourg

   Director of EPS    0
Grégoire de Spoelberch    Belgium   

c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940

Luxembourg

  

Director of AB InBev, the Stichting and EPS; CEO of GDS

Consult SA2

   < 0.1%
Alexandre Van Damme    Belgium   

c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940

Luxembourg

   Director of AB InBev, the Stichting and EPS    0.105%
Comtesse Edwine van der Straten Ponthoz    Belgium   

c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940

Luxembourg

   Director of EPS    < 0.1%
Maximilien de Limburg Stirum    Belgium   

c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940

Luxembourg

   Director of EPS, Chairman of SFI3    < 0.1%
Valentine De Pret Roose de Calesberg    Belgium   

c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940

Luxembourg

   Director of EPS    0
Paul Cornet de Ways Ruart    Belgium   

c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940

Luxembourg

   Director of AB InBev, the Stichting and EPS    < 0.1%
Sébastien Delloye    Belgium    c/o Eugenie Patri Sebastien S.A., 488, route de Longwy, L-1940 Luxembourg    Director of EPS    < 0.1%

 

1

The principal business of BT Group Plc is developing and selling communications propositions and services and its principal business address is BT Centre, 81 Newgate St, London EC1A 7AJ, United Kingdom.

2

The principal business of GDS Consult SA is private equity and real estate investments and its address is Rue de l’Eglise 147, B-1150 Woluwe St. Pierre, Belgium.

3

The principal business of SFI is equity investments and its address is 488, route de Longwy L-1940 Luxembourg.


ANNEX A-4

Directors of Rayvax

 

Name

  

Citizenship

  

Business Address

  

Present Principal Occupation

  

Beneficial
Ownership of

AB InBev

Ordinary

Shares

Arnoud de Pret Roose de Calesberg    Belgium   

c/o Rayvax SA Square Vergote 19

1200 Brussels

   Director of several companies, including Rayvax    <0.01%
Gérard Lamarche    Belgium    c/o Rayvax SA Square Vergote 19 1200 Brussels    Director of several companies, including Rayvax    <0.01%
Lavinia de Pret Roose de Calesberg    Belgium    c/o Rayvax SA Square Vergote 19 1200 Brussels    Director of several companies, including Rayvax    0
Valentine de Pret Roose de Calesberg    Belgium    c/o Rayvax SA Square Vergote 19 1200 Brussels    Director of several companies, including Rayvax    0
Elinor de Pret Roose de Calesberg    Belgium    c/o Rayvax SA Square Vergote 19 1200 Brussels    Director of several companies, including Rayvax    0


ANNEX A-5

Directors of Fonds Baillet Latour

 

Name

  

Citizenship

  

Business Address

  

Present Principal Occupation

  

Beneficial
Ownership of

AB InBev

Ordinary

Shares

Yvan de Launoit    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour, and deputy director of the CNRS1

   <0.1%
Pierre-Olivier Beckers-Vieujant    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Grégoire de Spoelberch    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour and AB InBev

   <0.1%
Benoit de Spoelberch    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Alain De Waele    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Thomas Leysen    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Chairman of Fonds Baillet

Latour, Umicore and Mediahuis2

   <0.1%
Sybille van der Straten Ponthoz    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Anne de Paepe    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

   Director of Fonds Baillet Latour    <0.1%
André Querton    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Diane de Spoelberch-Adriaenssen    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Eric Speeckaert    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Fransiscus van Daele    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

Director of Fonds Baillet

Latour

   <0.1%
Elinor de Pret Roose de Calesberg    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

   Director of Fonds Baillet Latour    <0.1%
Stichting Fonds InBev Baillet Latour3    Netherlands   

Ceresstraat 1, Breda,

Netherlands

  

Director of Fonds Baillet

Latour

   <0.1%

 

1

The CNRS (Centre National de la Recherche Scientifique) is a French state scientific research organization, and its principal address is 3 rue Michel-Ange, 75 016 Paris, France.

2

The principal business of Umicore is materials technology and its principal business address is Broekstraat 31 Rue du Marais, 1000, Brussels, Belgium. The principal business of Mediahuis is international media and its principal business address is Katwilgweg 2, 2050 Antwerpen, Belgium.

3

The directors of Stichting Fonds InBev Baillet Latour are Arnoud de Pret Roose de Calesberg, Benoit de Spoelberch, Alain De Waele, Thomas Leysen and Kees Storm. Each of them has a less than 0.1% beneficial ownership in AB InBev shares.


ANNEX A-6

Directors of Fonds Voorzitter Verhelst

 

Name

  

Citizenship

  

Business Address

  

Present Principal Occupation or
Employment

  

Beneficial
Ownership of

AB InBev

Ordinary

Shares

Remans Mieke    Belgium    Brouwerijplein 1, 3000 Leuven, Belgium    Board member    < 0.1%
Degelin Ludo    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

   Board member    <0.1%
Hermans Luc    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

   Board member    <0.1%
Van Biesbroeck Jo    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

  

President of Fonds Voorzitter

Verhelst

   <0.1%
Verdoodt Isabelle    Belgium   

Brouwerijplein 1, 3000 Leuven,

Belgium

   Board member    <0.1%


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

STICHTING ANHEUSER-BUSCH INBEV
by  

/s/ P. Cornet de Ways Ruart

Name:   P. Cornet de Ways Ruart
Title:   Class A Director
by  

/s/ Roberto Moses Thompson Motta

Name:   Roberto Moses Thompson Motta
Title:   Class B Director


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

BRC S.À.R.L
by  

*

Name:   Carlos Alberto Da Veiga Sicupira
Title:   Class A Director
by  

*

Name:   Jorge Paulo Lemann
Title:   Manager
by  

*

Name:   Marcel Herrmann Telles
Title:   Manager
*By  

/s/ Roberto Moses Thompson Motta

  Roberto Moses Thompson Motta
  Attorney-in-Fact
 

/s/ André Costa Coelho de Souza

  André Costa Coelho de Souza
  Attorney-in-Fact


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

EUGÉNIE PATRI SÉBASTIEN S.A.
by  

/s/ G. de Spoelberch

Name:   G. de Spoelberch
Title:   Director
by  

/s/ P. Cornet de Ways Ruart

Name:   P. Cornet de Ways Ruart
Title:   Director
by  

/s/ Alexandre Van Damme

Name:   Alexandre Van Damme
Title:   Director


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

RAYVAX SOCIÉTÉ D INVESTISSEMENTS S.A.
by  

/s/ Valentine de Pret Roose de Calesberg

Name:   Valentine de Pret Roose de Calesberg
Title:   Director
by  

/s/ Arnoud de Pret Roose de Calesberg

Name:   Arnoud de Pret Roose de Calesberg
Title:   Director


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

FONDS BAILLET LATOUR CV

*

Name:   Alain De Waele
  Director

*

Name:   Thomas Leysen
  Director
*By  

/s/ Jan Vandermeersch

  Jan Vandermeersch
  Attorney-in-Fact


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

FONDS VOORZITTER VERHELST SRL

*

Name: Luc Hermans
     Director

*

Name: Jo Van Biesbroeck
     Director
*By  

/s/ Jan Vandermeersch

  Jan Vandermeersch
  Attorney-in-Fact


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

JORGE PAULO LEMANN

*

Name: Jorge Paulo Lemann
*By  

/s/ Roberto Moses Thompson Motta

  Roberto Moses Thompson Motta
  Attorney-in-Fact
 

/s/ André Costa Coelho de Souza

  André Costa Coelho de Souza
  Attorney-in-Fact


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

CARLOS ALBERTO DA VEIGA SICUPIRA

*

Name: Carlos Alberto Da Veiga Sicupira
*By  

/s/ Roberto Moses Thompson Motta

  Roberto Moses Thompson Motta
  Attorney-in-Fact
 

/s/ André Costa Coelho de Souza

  André Costa Coelho de Souza
  Attorney-in-Fact


Signature

After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct.

Date: November 29, 2021

 

MARCEL HERRMANN TELLES

*

Name: Marcel Herrmann Telles
*By  

/s/ Roberto Moses Thompson Motta

  Roberto Moses Thompson Motta
  Attorney-in-Fact
 

/s/ André Costa Coelho de Souza

  André Costa Coelho de Souza
  Attorney-in-Fact


EXHIBIT INDEX

 

Exhibit
No

  

Description

2.1    Consolidated Articles of Association of Anheuser-Busch InBev SA/NV (English-language translation) (incorporated by reference to Exhibit 99.1 to the Current Report on Form 6-K filed by Anheuser-Busch InBev SA/NV on May 13, 2021).
2.2    2016 AK Shareholders’ Agreement, dated April 11, 2016 (incorporated by reference from Amendment No. 16 to the Schedule 13D relating to Ambev S.A. filed by (among others) Former AB InBev, the Stichting and EPS on April 18, 2016).
2.3    Funds Voting Agreement, effective November 1, 2015 (incorporated by reference to Amendment No. 15 to the Schedule 13D relating to Ambev filed by (among others) Former AB InBev, the Stichting and EPS on March 9, 2015).
2.4    Voting and Support Agreement relating to Anheuser-Busch InBev SA/NV, dated October 8, 2016 (incorporated by reference to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on November 2, 2016).
2.5    Powers of Attorney (incorporated by reference to the Amendment No. 1 to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on June 16, 2021).
2.6    Powers of Attorney (incorporated by reference to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on November 2, 2016).
2.7    Joint Filing Agreement pursuant to Rule 13d-1(k) (incorporated by reference to the Schedule 13D relating to Anheuser-Busch InBev SA/NV filed by (among others) the Stichting, BRC, EPS and Rayvax on November 2, 2016).
Anheuser Busch Inbev SA NV (NYSE:BUD)
Historical Stock Chart
Von Jun 2022 bis Jul 2022 Click Here for more Anheuser Busch Inbev SA NV Charts.
Anheuser Busch Inbev SA NV (NYSE:BUD)
Historical Stock Chart
Von Jul 2021 bis Jul 2022 Click Here for more Anheuser Busch Inbev SA NV Charts.